The FDA has unveiled its new Digital Health Center of Excellence as a major addition to the organization's capabilities and support of digital technology in patient care. The new agency unit will operate within the Center for Devices and Radiological Health (CDRH) located in Silver Spring, Maryland.
Amazon has chosen to partner with healthcare information and technology innovator Sharecare to accelerate and improve the performances of its Alexa platform used in healthcare settings. Sharecare is a healthcare and wellness company that aggregates and shares a broad array of healthcare information from a variety of trusted resources. It is also a savvy health and wellness application developer that provides numerous and valuable tools.
Gilead Sciences (NASDAQ: GILD) has communicated that it is acquiring Immunomedics (NASDAQ: Immuno) for $21 billion.
Resourceful healthcare marketing teams retracing steps to find and deploy under-utilized digital assets
Apple expands health and wellness business with blood oxygen reading Series 6 Apple Watch and Fitness+ workout video subscription service
.Apple's new Series 6 Apple Watch can read its wearer's blood oxygen levels and Apple's new Fitness+ workout video subscription service will add new sessions every week! Read more here...
Know where your healthcare audience is on social media now and in the future
It’s easy for healthcare marketing executives to assume their healthcare social media audience (customers) are in the same place where they were last week or last month. However, an action-packed 2020 is still generating new changes across the marketing landscape each day. It’s time to validate where targeted social media audiences to prepare for 2021.
Nestle’s Health Sciences unit has announced it is acquiring Brisbane, California -based Aimmune Therapeutics for $2.6 billion (NASDAQ: AIMT). Early in January 2020, the FDA approved Aimmune’s Palforzia (Arachis Hypogaea) drug which is the first therapy specifically indicated to treat peanut allergies. Its approval was welcomed by parents, allergists, immunologists and other members of the medical community involved in pediatrics and the treatment of food-borne allergies.
The healthcare business unit of Alphabet/Google, Verily Life Sciences, is exploring its opportunities in the health insurance sector. It is launching a new business unit referred to as "Coefficient Insurance Company". This is not a self-contained Alphabet-backed venture. Verily is partnering with Swiss Re to develop and commercialize this unique endeavor.
Ebola persists as a threat in Africa despite widespread vigilance and responsive containment measures
According to the World Health Organization (WHO), an Ebola outbreak in western Democratic Republic of Congo (DRC) has sickened over 100 people and has claimed the lives of 43 of them. Ebola emerged on June 1st in Mbandaka, a city of about1 million people on the River Congo. DRC had just declared its 2 year battle against an earlier Ebola outbreak over that had killed over 2,200 lives.
Momenta acquisition fuels Johnson & Johnson's expansion in autoimmune therapy
Johnson & Johnson (NYSE: JNJ) is acquiring Cambridge, Massachusetts based Momenta Pharmaceuticals for $6.5 billion. Founded in 2001, Momenta (NASDAQ: MNTA) posted sales of $23.9 million in 2019. Momenta's growth trajectory was about to take off based on its clinical research focus in rare diseases and advanced molecules.
Amazon is expanding its employee health program by contracting with Crossover Health to operate 20 primary care clinics in 5 states to provide care for Amazon warehouse and operations facility employees and their dependents.
Hematologists and Oncologists Welcome the approval of Inqovi. Astex Pharmaceuticals, a division of Otsuka (OTCMKTS: OTSKY) has received FDA approval for Inqovi (decitabine and cedazuridine). It is indicated for the treatment of myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) in adult patient populations. Inqovi is a significant therapeutic advancement in that it is administered via oral tablet.
VillageMD and Walgreens Boots Alliance Join Forces In A Robust Primary Care And Pharmacy Services Partnership. Walgreens Boots Alliance (NASDAQ: WBA) has announced it is investing approximately $`1 billion of equity and convertible debt in a deal with VillageMD. The business agreement is centered on a large scale primary practice business initiative comprised of VillageMD staffing and managing primary care clinics operating in Walgreens stores.
Capital Rx’s precision pricing strategy based on accuracy and technology attracts Walmart’s attention
Walmart is continuing to expand its healthcare and pharmacy services nationwide. One of its latest strategic decisions involves a partnership with Capital Rx, a newer PBM with rich pharmacy benefits, drug pricing, technology and client service attributes. One of the pivotal assets Capital Rx has developed is its " Clearinghouse Model" advanced pricing analytics application. It pinpoints, extr...
Roche and Genentech Continue To Demonstrate Leadership In Oncology With FDA Approval of Phesgo
The FDA has approved Phesgo (pertuzumab, trastuzumab and hyaluronidase–zzxf) to treat adult patients with HER2-positive breast cancer that has spread to other parts of the body and for treatment of adult patients with early HER2-positive breast cancer. Phesgo is an injection that is administered under the skin and was developed by Genentech, a South San Francisco based business unit of Roche (OTCMKT...